Trial intelligence / Profile preview

Supplementary Oxygen Therapy after Limb Debridement and Reconstruction Surgery in Infected Extremity Fractures (SOLDIER)

2026-525871-24-00Phase 2Authorised

Sponsor
Amsterdam University Medical Center
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of oxygen in fracture-related infection (FRI) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Number of subjects included after one year study duration, Number of hyperbaric oxygen therapy (HBOT) sessions completed per subject and 1 more. Planned start Jun 2026; status: authorised.

02

Drugs

oxygen
03

Conditions

fracture-related infection (FRI)

Beyond the preview

Go deeper on 2026-525871-24-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2026-525871-24-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call